Physician

Nannette Rene Crowley, M.D.

According to 2025 Medicare claims, Nannette Crowley, M.D. (NPI: 1902841307) practices rheumatology in the Warner Robins, GA market, with the plurality of this provider's patient population coming from Peach, GA. This provider's primary affiliated billing organization is HEART OF GEORGIA RHEUMATOLOGY LLC (NPI: 1013312040; TIN: 364590006) and primary practice location at 31201-1471. Crowley is affiliated with the TC2, LLC (ACO ID: A3365), participating under the MSSP model.

Crowley's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 340 traditional Medicare patients, billed 91,565 HCPCS/CPT codes, and received $1,595,900 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 1,524 prescription claims across 330 beneficiaries totaling $1,432,881 in drug costs, led by Enbrel Sureclick (Etanercept). DME data shows 26 claims. Open Payments data shows 185 records totaling $3,339. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $1,187,587 and ending at $1,595,900. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	520	86,160	$1,187,587
2016	563	111,010	$1,669,400
2017	545	104,024	$1,723,691
2018	525	102,840	$1,705,124
2019	489	114,530	$2,039,590
2020	477	123,308	$1,901,762
2021	439	91,386	$1,615,430
2022	416	74,715	$1,083,133
2023	388	74,221	$1,139,680
2024	340	91,565	$1,595,900

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	409	3,814	$1,812,511
2016	419	4,076	$2,196,933
2017	397	3,703	$2,183,921
2018	375	3,529	$2,665,623
2019	363	3,511	$2,817,934
2020	354	3,122	$2,625,784
2021	352	2,906	$3,151,260
2022	352	2,844	$3,520,829
2023	358	2,032	$2,671,212
2024	330	1,524	$1,432,881

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	26	$29,807
2019	N/R	26	$28,686
2020	N/R	26	$29,352
2021	N/R	26	$32,458
2022	N/R	26	$31,819
2023	N/R	24	$31,567
2024	N/R	26	$32,109

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	127	127	$112
96413	Administration of chemotherapy into vein, 1 hour or less	44	199	$94
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	173	325	$88
96365	Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less	49	253	$47
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	124	156	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Enbrel Sureclick	Etanercept	25	924	$239,405
Humira(Cf) Pen	Adalimumab	25	758	$181,121
Cosentyx Sensoready (2 Pens)	Secukinumab	18	504	$140,556
Remicade	Infliximab	15	714	$117,323
Orencia Clickject	Abatacept	16	448	$96,386

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J1569	Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg	N	N/R	13	$27,824
Q2052	Services, supplies and accessories used in the home for the administration of intravenous immune globulin (ivig)	N	N/R	13	$4,285

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	185	$3,339	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Nannette Rene Crowley, M.D.?

Tedicare shows public-source Medicare data for Nannette Rene Crowley, M.D. (NPI 1902841307), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Nannette Rene Crowley, M.D. have ACO affiliation data?

Nannette Rene Crowley, M.D. is shown with ACO affiliation data for TC2, LLC (MSSP, ACO ID A3365).

What billing organization is linked to Nannette Rene Crowley, M.D.?

Nannette Rene Crowley, M.D. is linked to HEART OF GEORGIA RHEUMATOLOGY LLC (billing NPI 1013312040) in the available physician profile data.

Does Nannette Rene Crowley, M.D. have Open Payments data?

Nannette Rene Crowley, M.D. has 185 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.